To illustrate the effect of SLC7A9 on ferroptosis, gastric cancer cells were treated with ferroptosis inhibitors (liproxstatin-1 and ferrostatin-1) or a ferroptosis inducer (erastin), and cell viability was observed. Here, SLC7A9 is linked to gastric cancer.